These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27028699)

  • 41. Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity.
    Ali KF; Shukla AP; Aronne LJ
    Expert Rev Clin Pharmacol; 2016; 9(1):27-34. PubMed ID: 26512740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-Obesity Medication Use in Children and Adolescents with Prader-Willi Syndrome: Case Review and Literature Search.
    Goldman VE; Naguib MN; Vidmar AP
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy of intranasal oxytocin in patients with Prader-Willi syndrome: A systematic review and meta-analysis.
    Shalma NM; Alsharabasy MA; Taha AM; Alsawareah A; Manirambona E; Ahmed SK; Mohamed MR; Taha NA; Abd-ElGawad M
    Diabetes Metab Syndr; 2023 Feb; 17(2):102711. PubMed ID: 36774885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial.
    Kuppens RJ; Donze SH; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):979-987. PubMed ID: 27486141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
    Goldstone AP; Holland AJ; Butler JV; Whittington JE
    Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome.
    Haqq AM; Stadler DD; Rosenfeld RG; Pratt KL; Weigle DS; Frayo RS; LaFranchi SH; Cummings DE; Purnell JQ
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3573-6. PubMed ID: 12915638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Naltrexone and fluoxetine in Prader-Willi syndrome.
    Benjamin E; Buot-Smith T
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):870-3. PubMed ID: 8340312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and validation of the Pediatric-Youth Hyperphagia Assessment for Prader-Willi syndrome.
    Cho SY; Kang D; Im M; Yang A; Kim MS; Kim J; Noh ES; Kwon EK; Choi E; Han S; Park YA; Kwak MJ; Kim Y; Cho J; Jin DK
    Epidemiol Health; 2022; 44():e2022014. PubMed ID: 35038830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxytocin treatment in children with Prader-Willi syndrome: A double-blind, placebo-controlled, crossover study.
    Miller JL; Tamura R; Butler MG; Kimonis V; Sulsona C; Gold JA; Driscoll DJ
    Am J Med Genet A; 2017 May; 173(5):1243-1250. PubMed ID: 28371242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioral and psychiatric disorders in Prader-Willi syndrome: a population study in Japan.
    Hiraiwa R; Maegaki Y; Oka A; Ohno K
    Brain Dev; 2007 Oct; 29(9):535-42. PubMed ID: 17314021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Obesity management in Prader-Willi syndrome.
    Salehi P; Leavitt A; Beck AE; Chen ML; Roth CL
    Pediatr Endocrinol Rev; 2015 Mar; 12(3):297-307. PubMed ID: 25962207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aberrant, autistic, and food-related behaviors in adults with Prader-Willi syndrome. The comparison between young adults and adults.
    Ogata H; Ihara H; Gito M; Sayama M; Murakami N; Ayabe T; Oto Y; Nagai T; Shimoda K
    Res Dev Disabil; 2018 Feb; 73():126-134. PubMed ID: 29324255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypothalamic loss of Snord116 and Prader-Willi syndrome hyperphagia: the buck stops here?
    Rodriguez JA; Zigman JM
    J Clin Invest; 2018 Mar; 128(3):900-902. PubMed ID: 29376891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychopharmacogenetic aspects of Prader-Willi syndrome.
    Tu JB; Hartridge C; Izawa J
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1137-40. PubMed ID: 1429418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of topiramate in adults with Prader-Willi syndrome.
    Shapira NA; Lessig MC; Lewis MH; Goodman WK; Driscoll DJ
    Am J Ment Retard; 2004 Jul; 109(4):301-9. PubMed ID: 15176917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prader-Willi Syndrome: clinical concerns for the orthopaedic surgeon.
    Kroonen LT; Herman M; Pizzutillo PD; Macewen GD
    J Pediatr Orthop; 2006; 26(5):673-9. PubMed ID: 16932110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The modified Atkins diet in children with Prader-Willi syndrome.
    Felix G; Kossoff E; Barron B; Krekel C; Testa EG; Scheimann A
    Orphanet J Rare Dis; 2020 Jun; 15(1):135. PubMed ID: 32493369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Obsessive-compulsive symptoms in Prader-Willi and "Prader-Willi-Like" patients.
    State MW; Dykens EM; Rosner B; Martin A; King BH
    J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):329-34. PubMed ID: 10087695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A model to characterize psychopathological features in adults with Prader-Willi syndrome.
    Thuilleaux D; Laurier V; Copet P; Tricot J; Demeer G; Mourre F; Tauber M; Jauregi J
    Am J Med Genet A; 2018 Jan; 176(1):41-47. PubMed ID: 29150898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liraglutide for Weight Management in Children and Adolescents With Prader-Willi Syndrome and Obesity.
    Diene G; Angulo M; Hale PM; Jepsen CH; Hofman PL; Hokken-Koelega A; Ramesh C; Turan S; Tauber M
    J Clin Endocrinol Metab; 2022 Dec; 108(1):4-12. PubMed ID: 36181471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.